These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia. Hansen L, Jones RM, Kingdon D. J Psychopharmacol; 2004 Sep; 18(3):384-7. PubMed ID: 15358982 [Abstract] [Full Text] [Related]
27. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. Cortese L, Caligiuri MP, Williams R, Schieldrop P, Manchanda R, Malla A, Harricharan R. J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344 [Abstract] [Full Text] [Related]
34. Neuroleptic-induced panic attacks in a patient with delusional depression. Bachmann KM, Modestin J. J Nerv Ment Dis; 1987 Jun; 175(6):373-5. PubMed ID: 2884274 [Abstract] [Full Text] [Related]
36. Quetiapine in patients with borderline personality disorder: an open-label trial. Adityanjee, Romine A, Brown E, Thuras P, Lee S, Schulz SC. Ann Clin Psychiatry; 2008 Jun; 20(4):219-26. PubMed ID: 19034754 [Abstract] [Full Text] [Related]
38. De novo induction of obsessive-compulsive symptoms with quetiapine in a patient with borderline personality disorder. Alexander J. Aust N Z J Psychiatry; 2009 Dec; 43(12):1185. PubMed ID: 20001420 [No Abstract] [Full Text] [Related]